Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk

Avinash Maganty, E. Charles Osterberg, Ranjith Ramasamy

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Testosterone replacement therapy (TRT) use is increasing, primarily in men with symptomatic hypogonadism. There are many benefits associated with TRT use, including improved sexual function, improved bone mineral density, and increased free fat mass and strength. As TRT use increases, its role on cardiovascular health must be explored. While previous evidence identified no adverse cardiovascular risks associated with TRT use, more recent studies suggest that there may be an associated risk, especially in elderly men and younger men with cardiac disease. Care must be taken with TRT use in these groups of men by careful monitoring for cardiac dysfunction. While testosterone therapy has many benefits and may generally be well tolerated, those prescribing the therapy must be cognizant of the potential adverse cardiovascular risks and advise men on the potential risks versus benefits.

Original languageEnglish (US)
Pages (from-to)340-344
Number of pages5
JournalAmerican Journal of Men's Health
Volume9
Issue number4
DOIs
StatePublished - Jul 19 2015
Externally publishedYes

Keywords

  • cardiovascular risk
  • testosterone replacement therapy (TRT)

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Health(social science)

Fingerprint Dive into the research topics of 'Hypogonadism and Testosterone Therapy: Associations With Cardiovascular Risk'. Together they form a unique fingerprint.

  • Cite this